Mega Lifesciences PCL (BKK:MEGA)
Thailand · Delayed Price · Currency is THB 37.75
+0.25 (0.67%)
Jul 3, 2026, 4:38 PM ICT
Mega Lifesciences PCL Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 2,067 | 1,912 | 2,012 | 1,993 | 2,242 | 1,947 |
Depreciation & Amortization | 274.09 | 278.13 | 277.74 | 279.98 | 265.18 | 268.86 |
Other Amortization | 5.19 | 5.19 | 5.69 | 5.89 | 6.83 | 5.57 |
Loss (Gain) From Sale of Assets | -5.42 | -5.32 | -2.65 | -2.87 | -2.08 | -3.51 |
Asset Writedown & Restructuring Costs | -0.79 | -0.8 | -0.59 | -0.54 | 8.59 | 28.02 |
Loss (Gain) on Equity Investments | 7.64 | 0.33 | -0.15 | -0.07 | -0.18 | 1.51 |
Provision & Write-off of Bad Debts | 8.38 | 7.78 | 3.68 | 12.17 | 5.83 | 3.09 |
Other Operating Activities | 335.57 | 235.21 | 251.64 | 238.72 | 70.4 | 39.8 |
Change in Accounts Receivable | -665.53 | -442.14 | 231.3 | -322.23 | -631.47 | 18.02 |
Change in Inventory | -312.91 | -82.38 | 447.19 | 569.37 | -576.69 | -273.63 |
Change in Accounts Payable | 218.69 | 67.31 | -278.66 | -885.27 | 364.68 | 375.68 |
Change in Other Net Operating Assets | 1,127 | 795.14 | -546.28 | 38.65 | 243.99 | 316.59 |
Operating Cash Flow | 3,058 | 2,770 | 2,401 | 1,926 | 1,997 | 2,727 |
Operating Cash Flow Growth | 35.95% | 15.37% | 24.65% | -3.51% | -26.78% | 67.35% |
Capital Expenditures | -490.01 | -663.89 | -247.53 | -274.65 | -304.6 | -151.4 |
Sale of Property, Plant & Equipment | 4.39 | 4.28 | 17.72 | 4.53 | 2.86 | 6.47 |
Cash Acquisitions | -28.19 | - | - | - | -9.25 | - |
Sale (Purchase) of Intangibles | -2.89 | -3.12 | -9.76 | -18.93 | -8.14 | -8.38 |
Investment in Securities | -6.38 | -6.38 | 178.14 | -20.11 | -1.75 | -122.57 |
Other Investing Activities | 86.1 | 84.43 | 62.87 | 59.14 | 40.07 | 11.19 |
Investing Cash Flow | -436.97 | -584.69 | 1.45 | -250.01 | -280.83 | -264.68 |
Short-Term Debt Issued | - | 205.23 | 215.37 | - | 65.2 | - |
Total Debt Issued | 205.23 | 205.23 | 215.37 | - | 65.2 | - |
Short-Term Debt Repaid | - | - | - | -148.66 | - | -309.49 |
Long-Term Debt Repaid | - | -57.64 | -60.16 | -88.6 | -58.1 | -53.52 |
Total Debt Repaid | -51.63 | -57.64 | -60.16 | -237.26 | -58.1 | -363.01 |
Net Debt Issued (Repaid) | 153.6 | 147.59 | 155.21 | -237.26 | 7.1 | -363.01 |
Common Dividends Paid | -1,395 | -1,395 | -1,395 | -1,439 | -1,406 | -922.94 |
Other Financing Activities | -56.09 | -49.51 | -38.04 | -31.75 | -34.76 | -27.93 |
Financing Cash Flow | -1,297 | -1,297 | -1,277 | -1,708 | -1,433 | -1,314 |
Foreign Exchange Rate Adjustments | -601.77 | -78.9 | -19.42 | -64.92 | -26.76 | 42.98 |
Net Cash Flow | 721.95 | 809.95 | 1,106 | -96.74 | 255.77 | 1,191 |
Free Cash Flow | 2,568 | 2,107 | 2,154 | 1,652 | 1,692 | 2,575 |
Free Cash Flow Growth | 45.20% | -2.20% | 30.39% | -2.38% | -34.30% | 84.62% |
Free Cash Flow Margin | 17.84% | 14.84% | 14.00% | 10.51% | 10.76% | 18.17% |
Free Cash Flow Per Share | 2.95 | 2.42 | 2.47 | 1.90 | 1.94 | 2.95 |
Cash Interest Paid | 56.09 | 49.51 | 38.04 | 31.75 | 29.85 | 27.93 |
Cash Income Tax Paid | 384.26 | 373.99 | 362.3 | 423.09 | 389.5 | 362.76 |
Levered Free Cash Flow | 2,172 | 2,081 | 2,289 | 1,413 | 1,209 | 1,989 |
Unlevered Free Cash Flow | 2,210 | 2,116 | 2,314 | 1,433 | 1,227 | 2,006 |
Change in Working Capital | 366.83 | 337.93 | -146.45 | -599.47 | -599.49 | 436.66 |